Cargando…
Sa143 THE RISK OF COVID-19 IS HIGHER IN FEMALES USING PROTON PUMP INHIBITORS
Autores principales: | Ghoneim, Sara, Butt, Muhammad U., Saleh, Sherif, Fass, Ronnie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AGA Institute. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8108140/ http://dx.doi.org/10.1016/S0016-5085(21)01756-X |
Ejemplares similares
-
Fr001 PROTON PUMP INHIBITOR AND RISK OF SARS-COV-2 INFECTION: A MULTI-CENTER EXPERIENCE
por: Silverman, Anna L., et al.
Publicado: (2021) -
Fr581 EVALUATION OF SEQUENTIAL CHANGES IN THE INTESTINAL FLORA OF PATIENTS TAKING LOW-DOSE ASPIRIN AND A PROTON-PUMP INHIBITOR
por: Hirata, Yuki, et al.
Publicado: (2021) -
Sa127 AN IBD-RISK VARIANT IN PTPN2 PROMOTES CELLULAR UPTAKE OF SARS-COV-2, WHICH IS MITIGATED BY THE JAK INHIBITOR TOFACITINIB
por: Spalinger, Marianne, et al.
Publicado: (2021) -
Sa004 DECLINING COLORECTAL CANCER SCREENING IN THE AGE OF COVID-19
por: Torres, Jon Alexander, et al.
Publicado: (2021) -
Sa1318: IMPACT OF OBESITY ON OUTCOMES ASSOCIATED WITH ACUTE ALCOHOLIC PANCREATITIS
por: Pellegrini, James R., et al.
Publicado: (2022)